Photo from wikipedia
We thank Dr. Faber and colleagues for their reply. We agree that intravenous immunoglobulin therapy (IVIG) is not a remedy for all patients with idiopathic small fiber neuropathy (I-SFN). However,… Click to show full abstract
We thank Dr. Faber and colleagues for their reply. We agree that intravenous immunoglobulin therapy (IVIG) is not a remedy for all patients with idiopathic small fiber neuropathy (I-SFN). However, the study population was nonrepresentative of clinical practice, given the 75% screening exclusion of patients with SFN. Furthermore, the clinical relevance is limited because the reasons for exclusion were not provided, other than the 16% exclusion for autoimmune comorbidities.1 These are precisely the patients who should be considered for immunotherapy.2
Journal Title: Neurology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!